The Effects of colecalciferol supplementation on urine calcium.

  • Research type

    Research Study

  • Full title

    The Effects of colecalciferol supplementation on urine calcium and body composition in patients with spinal cord injury: A randomised controlled trial. A pilot study.

  • IRAS ID

    166802

  • Contact name

    Irina Gainullina

  • Contact email

    irina.gainullina@buckshealcare.nhs.uk

  • Sponsor organisation

    Buckinghamshire Healthcare NHS Trust

  • Duration of Study in the UK

    0 years, 12 months, 0 days

  • Research summary

    Vitamin D, often called “the sunshine vitamin”, is a hormone which our bodies make in response to sun exposure. However for vulnerable groups, like patients with spinal cord injury (SCI), sunlight can be an unreliable source of vitamin D. A recent observational study conducted in the National Spinal Injuries Centre found 67.8% of SCI patients were vitamin D deficient. This growing concern has led the UK Chief Medical Officer to restate Government advice on supplementing the diets in vulnerable groups of vitamin D supplement containing 10 microgram per day. However, SCI centre’s health professionals are concerned that these recommendations will increase the risk of developing calcinosis and renal calculi.

    Research questions: Does a daily prescription of vitamin D and calcium supplementation has an effect on urine-calcium excretion (a risk factor for renal calculi)? How can we use this to better understand the effect of vitamin D supplementation on body composition?

    The purpose of this trial is to (1) assess the effect of vitamin D (800 IU, 20 mcg) and supplemental calcium (1200 mg) for 60 days compared to vitamin D without calcium for the change in urinary calcium; (2) analyse the effect of vitamin D with calcium and vitamin D without calcium supplementation in optimising serum vitamin D concentration and; (3)their effect on body composition (body muscle and fat) by bioelectrical impedance/Dual energy X-ray absorptiometry (DEXA) and; (4) to assess the dietary intake of vitamin D and calcium in SCI patients with vitamin D deficiency (serum vitamin D between 25-50nmol/L) .

    Study design: Randomised controlled trial. Pilot study. Sample size: 60.

    We are randomising vitamin D deficient participants to receive daily vitamin D / calcium supplement and vitamin D in one of two experimental groups:
    Group1:800 iu (20 microgram) vitamin D3 (i.e colecalciferol) and supplemental calcium (1200 mg) for 2 months.
    Group 2: 800 iu (20 microgram) vitamin D3 (i.e colecalciferol) without supplemental calcium for the same length of time.

  • REC name

    South Central - Oxford B Research Ethics Committee

  • REC reference

    14/SC/1428

  • Date of REC Opinion

    18 Dec 2014

  • REC opinion

    Unfavourable Opinion